Clinician education · In development
Women’s Metabolic & Heart Health
From pregnancy and gestational diabetes through obesity treatment, GLP-1 medicines and midlife cardiovascular prevention.
Explore the planned curriculum ↓For physicians, PAs and NPs in primary care, obstetrics and gynecology, endocrinology and obesity medicine.
Turn a history into a care plan.
Recognizing pregnancy history is a starting point. Clinicians also need to decide which test to order, how to individualize treatment, what to explain about pregnancy and medicines, and who will follow up.
The proposed program, Obesity & Diabetes Care in Women: Clinical Decisions from Pregnancy to Midlife, connects these decisions through practical cases. Each case ends with a clinical decision, a patient explanation and an accountable next step.
The clinical foundation includes the ADA’s 2026 guidance on screening after gestational diabetes and preconception care and the 2025 Endocrine Society / European Society of Endocrinology pregnancy guideline, which addresses GLP-1 treatment transitions in people with type 2 diabetes.
Proposed learning objectives
Four decisions clinicians will practice.
Screening after gestational diabetes
Select appropriate postpartum and ongoing diabetes screening, explain the next step, and identify who will review and act on the result—even when pregnancy was years ago.
Obesity and diabetes treatment decisions
Compare behavioral care, medicines including GLP-1 therapies, referral and metabolic surgery where appropriate. Consider cardiovascular health, reproductive plans, patient preferences, cost and access.
Pregnancy planning and medication exposure
Apply current guidance and product-specific labeling to planned pregnancy or inadvertent GLP-1 exposure. Explain evidence limits and coordinate a treatment transition with continuing metabolic care.
A plan that carries into the next visit
Name the responsible clinician, agree on timing, and plan how results, missed appointments, side effects and treatment interruptions will be addressed.
Designed for decisions in practice.
The proposed 12-month series combines four 45-minute on-demand courses with two 60-minute live case conferences. The conferences revisit decisions learners find difficult.
See two example cases
A postpartum visit without completed screening
A woman attended her postpartum visit after gestational diabetes, but testing remains incomplete. Learners work through test selection, childcare and laboratory barriers, and responsibility for communicating the result.
Pregnancy plans during obesity treatment
A woman using a GLP-1 medicine wants to conceive soon. Learners review the particular product, reproductive plans and metabolic needs, then practice explaining a coordinated transition. A related case addresses inadvertent early exposure and what the evidence can and cannot establish.
These are fictional educational scenarios. Complete cases and clinical recommendations require faculty review before release.
Practical tools planned for learners
A pregnancy-history and metabolic assessment prompt, diabetes screening reference, treatment discussion worksheet, pregnancy-related medication review worksheet, and follow-up tracker.
Tools are planned to include sources and review dates. Patient-facing explanations will undergo patient review; any selected translations will be independently checked.
See the separate patient visit-summary example →How learning and practice change will be evaluated
Planned measures include participation and completion, pre- and post-activity knowledge and case decisions, and an intended practice change. A survey at 60–90 days will ask learners which changes they implemented and what barriers remain.
Reported practice change will be distinguished from demonstrated case performance. These measures do not establish improved patient outcomes. An outcomes report will summarize findings and remaining educational needs.
Education partners & grant supporters
Help bring the program to clinicians.
Educational grant support would help fund faculty review, case development, accessible course production, practical tools and outcomes evaluation. HEART RESERVE brings the pregnancy-history perspective and patient preparation resources to this work.
Current development status
CME/CE planning is being developed with Global Education Group. Funding, faculty validation, final accreditation details and launch timing remain pending. This overview does not offer enrollment or CME/CE credit.
Planned safeguards include independent faculty review, disclosure and management of relevant financial relationships, balanced treatment comparisons, and a clear separation between educational content and grant support.
Contact Lisa Zahakos, RPA-C, founder of HEART RESERVE.
lisazahakos@gmail.com
Program overview updated November 3, 2026. Educational scope only; individual treatment decisions belong with the treating clinical team.